Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study

Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study

Abstract Background Inosine pranobex (Isoprinosine®) is an immunomodulatory drug approved in several countries for the treatment of viral infections. This study compared the efficacy and safety of inosine pranobex versus placebo in subjects with clinically diagnosed influenza-like illness, including...

Full description

Bibliographic Details
Main Authors: Jiří Beran, Eva Šalapová, Marian Špajdel, on behalf of the Isoprinosine Study (EWO ISO-2014/1) Team
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Immunomodulator
Immunosenescence
Influenza
Inosine pranobex
Isoprinosine
Viral infection
Online Access:http://link.springer.com/article/10.1186/s12879-016-1965-5

Internet

http://link.springer.com/article/10.1186/s12879-016-1965-5

Similar Items